4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001209191-18-030609
Options or other derivatives
- Chief Scientific Officer acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Suri Anish Chief Scientific Officer | 2018-05-14 | Grant or award · Stock Options | +250,000 | 250,000 | D | ||
Loading xslF345X03/doc4.xml…